[Petechiae, suffusions and cytarabine-induced erythema in treatment of acute myeloid leukemia].
Taverna
C
C
Department für Innere Medizin Universitätsspital, Zürich.
Jacky
E
E
Sauter
C
C
D000368:Aged; D000964:Antimetabolites, Antineoplastic / Q000009:adverse effects* / Q000627:therapeutic use; D003561:Cytarabine / Q000009:adverse effects* / Q000627:therapeutic use; D003937:Diagnosis, Differential; D003875:Drug Eruptions / Q000175:diagnosis*; D005260:Female; D006801:Humans; D015470:Leukemia, Myeloid, Acute / Q000188:drug therapy*; D011693:Purpura / Q000139:chemically induced*
D000964:Antimetabolites, Antineoplastic; D003561:Cytarabine